Peter Gennemark
Peter Gennemark
Researcher at AstraZeneca üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Integrative model of the response of yeast to osmotic shock
E Klipp, B Nordlander, R Krüger, P Gennemark, S Hohmann
Nature biotechnology 23 (8), 975-982, 2005
Models from experiments: combinatorial drug perturbations of cancer cells
S Nelander, W Wang, B Nilsson, QB She, C Pratilas, N Rosen, ...
Molecular systems biology 4 (1), 216, 2008
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
R Jörnsten, T Abenius, T Kling, L Schmidt, E Johansson, TEM Nordling, ...
Molecular systems biology 7 (1), 486, 2011
Structural and functional characterization of a specific antidote for ticagrelor
A Buchanan, P Newton, S Pehrsson, T Inghardt, T Antonsson, ...
Blood 125 (22), 3484-3490, 2015
Efficient algorithms for ordinary differential equation model identification of biological systems
P Gennemark, D Wedelin
IET systems biology 1 (2), 120-129, 2007
Benchmarks for identification of ordinary differential equations from time series data
P Gennemark, D Wedelin
Bioinformatics 25 (6), 780-786, 2009
A simple mathematical model of adaptation to high osmolarity in yeast
P Gennemark, B Nordlander, S Hohmann, D Wedelin
In silico biology 6 (3), 193-214, 2006
Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity
XR Peng, P Gennemark, G O'Mahony, S Bartesaghi
Frontiers in endocrinology 6, 174, 2015
Discovery of (3-(4-(2-oxa-6-azaspiro [3.3] heptan-6-ylmethyl) phenoxy) azetidin-1-yl)(5-(4-methoxyphenyl)-1, 3, 4-oxadiazol-2-yl) methanone (AZD1979), a melanin concentrating …
A Johansson, C Löfberg, M Antonsson, S von Unge, MA Hayes, ...
Journal of medicinal chemistry 59 (6), 2497-2511, 2016
Formal representation of the high osmolarity glycerol pathway in yeast
C Kühn, KVS Prasad, E Klipp, P Gennemark
Genome Informatics 2009: Genome Informatics Series Vol. 22, 69-83, 2010
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes
E Nyman, YJW Rozendaal, G Helmlinger, B Hamrén, MC Kjellsson, ...
Interface focus 6 (2), 20150075, 2016
A modeling approach for compounds affecting body composition
P Gennemark, R Jansson-Löfmark, G Hyberg, M Wigstrand, D Kakol-Palm, ...
Journal of pharmacokinetics and pharmacodynamics 40 (6), 651-667, 2013
Hemostatic effects of the ticagrelor antidote MEDI 2452 in pigs treated with ticagrelor on a background of aspirin
S Pehrsson, KJ Johansson, A Janefeldt, AS Sandinge, S Maqbool, ...
Journal of Thrombosis and Haemostasis 15 (6), 1213-1222, 2017
Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat
CC Johansson, P Gennemark, P Artursson, A Äbelö, M Ashton, ...
Journal of pharmacokinetics and pharmacodynamics 40 (1), 117-128, 2013
Systems biology reveals uncoupling beyond UCP1 in human white fat-derived beige adipocytes
E Nyman, S Bartesaghi, RM Rydfalk, S Eng, C Pollard, P Gennemark, ...
NPJ systems biology and applications 3 (1), 1-10, 2017
Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs
K Ploj, L Benthem, D Kakol‐Palm, P Gennemark, L Andersson, M Bjursell, ...
British journal of pharmacology 173 (18), 2739-2751, 2016
Quantifying and communicating uncertainty in preclinical human dose‐prediction
M Sundqvist, A Lundahl, MB Någård, U Bredberg, P Gennemark
CPT: pharmacometrics & systems pharmacology 4 (4), 243-254, 2015
Models for combinatorial perturbations of living biological systems
C Sander, S Nelander, WQ Wang, P Gennemark, B Nilsson
US Patent 8,577,619, 2013
Input estimation for drug discovery using optimal control and Markov chain Monte Carlo approaches
M Trägårdh, MJ Chappell, A Ahnmark, D Lindén, ND Evans, ...
Journal of pharmacokinetics and pharmacodynamics 43 (2), 207-221, 2016
Modeling energy intake by adding homeostatic feedback and drug intervention
P Gennemark, S Hjorth, J Gabrielsson
Journal of pharmacokinetics and pharmacodynamics 42 (1), 79-96, 2015
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20